AAD Member

AAD Member The official page for AAD Member dermatologists with up-to-date news, resources, and information from the American Academy of Dermatology.

Join AADA President Murad Alam for an update on the AADA response to proposed Medicare cutsAADA President Murad Alam, MD...
09/02/2026

Join AADA President Murad Alam for an update on the AADA response to proposed Medicare cuts

AADA President Murad Alam, MD, MSCI, MBA, FAAD, is hosting a town hall open to all members where he’ll provide updates on the Academy’s response to proposed Medicare cuts. The town hall will be held Sept. 8, 2026, at 8:00 p.m. Central.

🚨 The American Academy of Dermatology Association (AADA) engaged directly with the White House last week to advocate for...
09/01/2026

🚨 The American Academy of Dermatology Association (AADA) engaged directly with the White House last week to advocate for dermatologists on proposed payment policy issues.

AADA President Dr. Murad Alam, Board member Dr. Amy Derick, and Director of Health Policy and Payment Sharmila Sandhu, JD, met with the Domestic Policy Council (DPC) as members of the Same Day Care Coalition.

The discussion addressed the proposed 2027 Medicare Physician Fee Schedule reimbursement cuts and proposed changes to the policy. The DPC oversees the ex*****on of domestic policy decisions across areas such as education, healthcare, and energy.

Kavita Mariwalla, MD, FAAD, also joined them as a member of the Same Day Care Coalition and President of the American Society of Dermatologic Surgery.

A few days later, Dr. Alam met with the DPC to discuss issues affecting dermatologists under the Medicare Physician Fee Schedule, an opportunity that allowed dermatology's concerns to reach White House officials.

➡️ Visit www.aad.org/SOS to learn how the AADA continues to advocate on behalf of dermatologists and the patients they serve.

Dermatology residents Benjamin Cooper, DO, Taha Rasul, MD, and Anthony Concilla, DO, created this new AAD Boards Fodder ...
08/27/2026

Dermatology residents Benjamin Cooper, DO, Taha Rasul, MD, and Anthony Concilla, DO, created this new AAD Boards Fodder study chart that is "all about acne."

Learn how to manage cases from mild to severe, plus information on all the acne variants, including epidemiology, pathogenesis, clinical features, and treatment options.

Download the entire chart (plus dozens more!) in the AAD's Directions in Residency archive: https://www.aad.org/member/education/residents/fodder/pediatrics

An article in JAAD evaluated the association between the use of oral niacinamide and cardiovascular outcomes in patients...
08/27/2026

An article in JAAD evaluated the association between the use of oral niacinamide and cardiovascular outcomes in patients with multiple nonmelanoma skin cancers (NMSCs).

In a retrospective cohort study, patients with two or more NMSCs or bullous pemphigoid who began taking oral niacinamide, 500 mg or more, were matched 1:1 with niacinamide-naive controls.

Niacinamide use was associated with reduced risk of ST elevation myocardial infarction (STEMI) (0.9% vs. 1.6%) and peripheral vascular disease (4.7% vs. 6.3%). Cardiac arrest risk was also reduced, although it was not statistically significant. No significant differences were found in non-ST-segment elevation myocardial infarction (2.6% vs. 2.5%) or type 2 myocardial infarction (1.2% vs. 0.9%).

According to the authors, their findings suggest that niacinamide supplementation is not only safe from a cardiovascular perspective but also may be associated with a significant reduction in STEMI incidence which only persisted in patients with a history of atherosclerotic cardiovascular disease despite more than 75% of the overall study population already taking a lipid-lowering statin medication.

Learn more in the AAD's weekly: https://www.aad.org/dw/weekly/july-29-2026

Join AADA President Murad Alam for an update on the AADA response to proposed Medicare cutsAADA President Murad Alam, MD...
08/26/2026

Join AADA President Murad Alam for an update on the AADA response to proposed Medicare cuts

AADA President Murad Alam, MD, MSCI, MBA, FAAD, is hosting a town hall open to all members where he’ll provide updates on the Academy’s response to proposed Medicare cuts. The town hall will be held Sept. 8, 2026, at 8:00 p.m. Central.

AADA President Murad Alam, MD, MSCI, MBA, FAAD reviews the latest on what the AADA is doing to fight against the cuts to dermatology payments in the proposed 2027 Medicare physician fee schedule and how members can get involved.

The 2027 Annual Meeting presents four distinct opportunities to present innovative and impactful research in the field o...
08/26/2026

The 2027 Annual Meeting presents four distinct opportunities to present innovative and impactful research in the field of dermatology.

We offer abstract submissions for the following programs:

➡️ Gross & Microscopic Symposium
➡️ Resident & Fellows Symposium
➡️ Poster Exhibit
➡️ Late-Breaking Research (opens in Fall 2026)

Each abstract program is designed to highlight excellence across various stages of dermatologic research.

Get detailed information on each abstract program, including submission guidelines and deadlines at the link below.
https://www.aad.org/member/meetings-education/am27/faculty/abstracts

The AAD Cochrane Scholarship award program is founded on the goal of expanding the training in — and reach of — evidence...
08/23/2026

The AAD Cochrane Scholarship award program is founded on the goal of expanding the training in — and reach of — evidence-based medicine in dermatology.

Two Cochrane Scholars are awarded annually to develop a systematic review on a topic that supports clinical practice guideline development. Potential topics currently under consideration include chronic pruritus and atypical nevi.

The Academy considers a Cochrane systematic review to be the gold standard and supports training in this area. As a Scholar, the Academy will support your completion of online Cochrane Interactive Learning modules on conducting a systematic review before the commencement of your review.

The Academy will also support and expect scholars’ attendance at the Cochrane Colloquium, an in-person learning event, during award years in which the event is held. Each scholar will ultimately prepare and submit a publication-quality systematic review for consideration for publication in JAAD.

Applications will be accepted until the end of August 2026. Learn more:

Learn how two annual award recipients will receive a travel grant to attend the Cochrane Colloquium. Award recipients will be required to develop a systematic review in a dermatology area that will support AAD clinical guideline development, or update a...

Apply now for the 2027 AAD Resident Quality Improvement Award!The AAD is offering financial support to dermatology resid...
08/19/2026

Apply now for the 2027 AAD Resident Quality Improvement Award!

The AAD is offering financial support to dermatology residents engaged in quality improvement projects that help meet requirements for ACGME accreditation.

Receive up to $2,000 and recognition for the valuable work that is a required part of today’s training. Funds can help cover expenses of data collection, materials and supplies, and even travel to the AAD Annual Meeting for a presentation.

Selected applicants will be invited to reveal their quality improvement projects at the 2027 AAD Annual Meeting.

Deadline ends soon! Apply by Aug. 14, 2026:

Learn about the Resident Quality Improvement Award. The AAD is offering financial support to residents physicians engaged in quality improvement projects that help meet requirements for ACGME accreditation.

An article published in the International Journal of Women’s Dermatology evaluated the efficacy of spironolactone 100 mg...
08/18/2026

An article published in the International Journal of Women’s Dermatology evaluated the efficacy of spironolactone 100 mg daily for female pattern hair loss in premenopausal women.

Forty-eight women aged 21 to 45 years were randomly assigned to receive spironolactone 100 mg or placebo once daily for 24 weeks. Twice-daily minoxidil 3% solution was used for all participants. Efficacy was assessed by changes in hair density and diameter.

After treatment, hair density and diameter increased significantly in both treatment groups. The spironolactone group showed a greater increase in changes from baseline of terminal hair counts and hair diameters compared to the placebo group.

The authors concluded that oral spironolactone showed an additive effect to topical minoxidil in premenopausal women with mild-to-moderate female pattern hair loss.

Menstrual irregularities (37.5%) were the most common adverse event and were significantly higher in the spironolactone group.

Learn more in the AAD's Dermatology World Weekly newsletter. https://www.aad.org/dw/weekly/august-05-2026

Dermatologist Dr. David T. Harvey recently met with Taylor Anne Jones, a staff member for U.S. Rep. Brian Jack (R-GA), t...
08/17/2026

Dermatologist Dr. David T. Harvey recently met with Taylor Anne Jones, a staff member for U.S. Rep. Brian Jack (R-GA), to discuss the negative impact of the proposed 2027 Medicare Fee Schedule cuts.

We're asking all AAD members to do the same ➡️ meet their legislators in person to discuss the impact of the cuts on physicians and patient care.

Learn more and schedule your meeting at:

You can meet with your elected officials or their staff in their local district office or the office where you practice. This guide provides essential tips to ensure a smooth, productive visit that can build an impactful relationship.

Address

9500 W. Bryn Mawr Avenue, Suite 500
Rosemont, IL
60018

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Alerts

Be the first to know and let us send you an email when AAD Member posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share